Category: News and Commentaries

“Martis explained to The Center Square that the manufacturing and transportation of turbines to their destination typically requires overseas shipping…Continue readingExperts question economic, environmental value of wind power.

“Companies are more likely to take corporate social responsibility seriously if they have more women on their board of directors,…Continue readingFemale directors improve corporate social responsibility.

“We do not expect the controversy about ESG investing to disappear anytime soon. Much of it is healthy, such as…Continue readingThe Politics of Values-Based Investing.

“A new review from the Institute of Electrical and Electronics Engineers (IEEE) analyses over 600 peer-reviewed articles on 100 percent…Continue reading100 Percent Renewable Energy Systems Could Power the Globe By 2050.

“The same day Texas released its version of the index prohibitorum, it emerged that California would ban gasoline-powered cars by…Continue readingTexas’ Answer to ‘Woke’ Investing Looks Kind of Woke.

“Passive sustainable funds are growing strongly. But investors in these funds are at risk of a mismatch between what they…Continue readingWhy sustainable investors may rue being too passive.

“Util — a financial technology company with a focus on sustainability — has published a report ranking the top ten…Continue readingReport Calls for “Unbundling” ESG Metrics for Impactful Investment for SDGs.

“The evidence against claims related to ‘woke’ capitalism is thin. Both sides of the ESG debate make valid points while…Continue readingESG — A Defense, A Critique, And A Way Forward: An Evidence-Driven Pragmatic Perspective.

“To summarize, the analysis found that companies with higher initial ESG ratings experience greater subsequent stability of dividends and a…Continue readingCan High ESG Ratings Help Sustain Dividend Growth?

“Rather than proposing improved definitions and metrics based on better data, The Economist argues that ‘it is better to focus…Continue readingOn ESG Investing, The Economist Offers The Right Diagnosis But A Faulty Prescription.